With autonomy from its former parent, we think Sandoz can freely allocate resources to fit its best needs and grow the business. Sandoz is one of the largest biosimilars players in the world, and we ...

Reissue applications represent a very small fraction of the total number of applications filed at the USPTO each year. Indeed, at the midpoint ...

Liberals promised to ‘significantly reduce’ wait times for pharmaceuticals, which it acknowledged were longer than in other ...

Health Canada is supposed to issue rulings on new generics – which are copies of branded drugs whose patents have expired – ...

CID-103 is a potential best-in-class, anti-CD38 monoclonal antibody; binds to unique CD38 epitope Phase 1 study in adults with active and chronic active renal allograft AMR planned to initiate AMR is ...

Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced that its proprietary CDH17-targeting antibody-drug conjugate (ADC), 7MW4911, has received ...